OL-006 Efficacy, tolerability and safety of personalized low-dose IFN treatment in patients with HCV-related liver cirrhosis and severe complications

Xiaoling Fan; Wenyan Zhang; Yun-ru Li; Xiaojie Wang

首页> 外文期刊>International journal of infectious diseases : >OL-006 Efficacy, tolerability and safety of personalized low-dose IFN treatment in patients with HCV-related liver cirrhosis and severe complications

【24h】

OL-006 Efficacy, tolerability and safety of personalized low-dose IFN treatment in patients with HCV-related liver cirrhosis and severe complications

机译：OL-006个性化小剂量干扰素治疗对HCV相关性肝硬化和严重并发症的疗效，耐受性和安全性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International journal of infectious diseases :》 |2009年第1期|共1页
作者
Xiaoling Fan; Wenyan Zhang; Yun-ru Li; Xiaojie Wang;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of tolvaptan in the treatment of patients with decompensated liver cirrhosis and severe chronic kidney disease [J] . Arase Yoshitaka, Kagawa Tatehiro, Tsuruya Kota, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：托尔沃坦治疗失代偿性肝硬化患者和严重慢性肾病的疗效和安全性
2. IFN-αα induced psoriatic arthritis and HCV-related liver cirrhosis. Therapeutic options and patient’s opinion [J] . A. Cauli, G. Porru, A. Vacca, Reumatismo . 2008,第1期

机译：IFN-αα诱发银屑病关节炎和HCV相关的肝硬化。治疗选择和患者意见
3. The influence of clinical significant portal hypertension (stage Baveno 2) on safety, tolerability and efficacy of paritaprevir, ritonavir, ombitasvir, dasabuvir and ribavirin (PrOD plus R) in a real-world large cohort of genotype 1b HCV liver cirrhosis patients [J] . Trifan Anca, Singeap Ana Maria, Gheorghe Liana, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：临床显着门诊高血压（第BaveNo 2）对ParitaPrevir，Ritonavir，ObsitaSvir，Dasbuvir和利巴韦林（Prod Plus R）的安全，耐受性和功效的影响，在实际群体的基因型1B HCV肝硬化患者中
4. Therapy of Patients with Chronic Immune Thrombocytopenic Purpura (ITP): Efficacy, Tolerability, and Safety of a New Nanofiltered Intravenous Immunoglobulin [C] . H.-H. Wolf, S. Davies, G. Smith, European Haematology Association . 2002

机译：慢性免疫血小板减少症患者的治疗患者（ITP）：一种新的纳米过滤静脉内免疫球蛋白的疗效，耐受性和安全性
5. Efficacy, Tolerability and Safety of Operating Room Microlaryngoscopy Versus Office-Based Potassium Titanyl Phosphate (KTP) Laser Treatment of Benign Vocal Fold Lesions: A Longitudinal Prospective Evaluation of Multidimensional Voice Outcomes [D] . Chadwick, Keith Alan. 2020

机译：手术室微淋镜检查的功效，耐受性和安全性与良性声带病变的基于办事处的磷酸钾（KTP）激光治疗：多维语音结果的纵向前瞻性评估
6. Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma [O] . Soocheol Jeong, Hiroshi Aikata, Yoshio Katamura, 2007

机译：小剂量间歇性干扰素-α疗法治疗肝细胞癌后HCV相关性肝硬化
7. OL-006 Efficacy, tolerability and safety of personalized low-dose IFN treatment in patients with HCV-related liver cirrhosis and severe complications [O] . Fan Xiaoling, Zhang Wenyan, Li Yun-ru, 2009

机译：OL-006个性化小剂量干扰素治疗对HCV相关性肝硬化和严重并发症的疗效，耐受性和安全性

OL-006 Efficacy, tolerability and safety of personalized low-dose IFN treatment in patients with HCV-related liver cirrhosis and severe complications

著录项

相似文献

相关主题

期刊订阅